MID-VOLUME · MALE-LED
abiraterone Side Effects
abiraterone (also sold as Zytiga) sits MID-VOLUME #291 of 524 by FAERS report count. Lead signal: MALE-LED - 1% of sex-coded reports are female (75 F / 11,301 M). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 12,794
- FAERS reports
FDA Adverse Event Reporting System extract for abiraterone. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
abiraterone reporting skew - 1% of sex-coded reports are female (75 F / 11,301 M). Volume band MID-VOLUME #291 of 524 by FAERS report count; caseload WATCHLIST.
Mid-book FAERS page for abiraterone (Zytiga) (12,794 reports). Signature MALE-LED. Dominant age band on file: 75+. Educational reference only.
Counts from the openFDA FAERS extract (2010–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · MALE-LED.
DEATH leads 1,390 of 12,794 reports
MALE-LED reporters · age peak 75+
Male-led reporters (99% of sex-coded rows)
Age peak 75+ (4,055 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (2,176 reports, 17.0%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 1,344 |
| PROSTATE CANCER | 110 |
| ANAEMIA | 85 |
| MALIGNANT NEOPLASM PROGRESSION | 85 |
| DISEASE PROGRESSION | 79 |
| PROSTATE CANCER METASTATIC | 76 |
| FATIGUE | 64 |
| DECREASED APPETITE | 56 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 53 |
| SEPSIS | 51 |
| DIARRHOEA | 49 |
| PNEUMONIA | 49 |
| ASTHENIA | 47 |
| METASTASES TO BONE | 46 |
| THROMBOCYTOPENIA | 43 |
| ACUTE KIDNEY INJURY | 41 |
| PROSTATIC SPECIFIC ANTIGEN INCREASED | 41 |
| CONSTIPATION | 37 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (4,866, 38.0% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| FALL | 290 |
| ACUTE KIDNEY INJURY | 286 |
| PNEUMONIA | 262 |
| ASTHENIA | 254 |
| THERAPY INTERRUPTED | 250 |
| FATIGUE | 236 |
| URINARY TRACT INFECTION | 236 |
| HOSPITALISATION | 212 |
| DRUG INTERACTION | 206 |
| HYPOKALAEMIA | 206 |
| RHABDOMYOLYSIS | 203 |
| ANAEMIA | 193 |
| DYSPNOEA | 180 |
| ATRIAL FIBRILLATION | 157 |
| NAUSEA | 154 |
| SEPSIS | 152 |
| DIARRHOEA | 149 |
| VOMITING | 144 |
| DEHYDRATION | 140 |
| DIZZINESS | 128 |
How to read abiraterone FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 12,794 voluntary reports linked to abiraterone (Zytiga), 2010-2025. Death is listed on 2,176 (17.0%). Hospitalization appears on 4,866 (38.0%). Top co-reported indication: Prostate Cancer.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 1% of sex-coded reports are female (75 F / 11,301 M).
Read with abiraterone
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 12,807 FAERS cases (Δ 13 heavier vs abiraterone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · MALE-LED.
ABS(total_reports) peer at 12,758 FAERS cases (Δ 36 lighter vs abiraterone); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · MALE-LED.
ABS(total_reports) peer at 12,855 FAERS cases (Δ 61 heavier vs abiraterone); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · MALE-LED.
ABS(total_reports) peer at 12,726 FAERS cases (Δ 68 lighter vs abiraterone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · MALE-LED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 45.1 pp vs abiraterone's DEATH-HEAVY): CASELOAD · HOSP-MID.
abiraterone stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.